Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data (Q30642220)

25 June 2017

Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data (English)

1 reference

multidrug-resistant tuberculosis

25 June 2017

multiple drug resistance

0 references

tuberculosis

0 references

data sharing

0 references

1 reference

Mario C Raviglione

6

0 references

Fraser Wares

series ordinal

3

object named as

Fraser Wares

1 reference

25 June 2017

4

Matteo Zignol

1 reference

25 June 2017

2

Ernesto Jaramillo

1 reference

25 June 2017

Dennis Falzon

1

1 reference

PubMed ID

23743044

25 June 2017

Katherine Floyd

series ordinal

5

1 reference

25 June 2017

4 June 2013

1 reference

Lancet Infectious Diseases

25 June 2017

1 reference

25 June 2017

13

1 reference

25 June 2017

8

1 reference

25 June 2017

690-697

1 reference

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

25 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970130-0

7 January 2021

Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970130-0

7 January 2021

Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970130-0

7 January 2021

Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970130-0

7 January 2021

Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970130-0

7 January 2021

Totally drug-resistant tuberculosis in India.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970130-0

7 January 2021

Clonal expansion of multidrug-resistant and extensively drug-resistant tuberculosis, Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970130-0

7 January 2021

XDR Tuberculosis — Implications for Global Public Health

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970130-0

7 January 2021

Scale-up of multidrug-resistant tuberculosis laboratory services, Peru

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970130-0

7 January 2021

Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970130-0

7 January 2021

MDR tuberculosis--critical steps for prevention and control

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970130-0

7 January 2021

Tuberculosis, drug resistance, and the history of modern medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970130-0

7 January 2021

Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970130-0

7 January 2021

Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970130-0

7 January 2021

Delamanid for multidrug-resistant pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970130-0

7 January 2021

A systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970130-0

7 January 2021

10.1016/S1473-3099(13)70130-0

Identifiers

DOI

1 reference

25 June 2017

1 reference

PubMed ID

23743044